Unknown OBSERVATIONAL NCT05709717

Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases

Sponsor: Kantonsspital Winterthur KSW

Conditions Anal Fissure Perianal Crohn Disease Perianal Fistula Perianal Fistula Due to Crohn's Disease Rectovaginal Fistula

Interventions Regenerative therapy with SVF-PRP to supplement perianal surgery

Updated 4 times since 2023 Last updated: Jan 24, 2023 Started: Jan 25, 2023 Primary completion: Dec 31, 2023 Completion: Jan 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Anal Fissure and Perianal Crohn Disease and is currently ongoing. Kantonsspital Winterthur KSW leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Feb 2025 — Present [monthly]

Unknown

Status: Not Yet Recruiting → Unknown
Sep 2024 — Feb 2025 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Mar 2023 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kantonsspital Winterthur KSW

Data source: Kantonsspital Winterthur KSW

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Winterthur, Switzerland